Weekly Tech Digest: NVIDIA's $1B AI Drug Discovery, Google's TranslateGemma, and Kubernetes 1.35
NVIDIA & Eli Lilly Launch $1B AI Drug Discovery Venture to Revolutionize Medicine In a landmark move for the biopharmaceutical industry, NVIDIA and Eli Lilly have announced a joint AI drug discovery lab, backed by a planned investment of up to $1 billion over five years. This collaboration aims to transform key aspects of drug development into a precise engineering discipline. By leveraging high-performance computing and specialized AI agents, the partnership will accelerate research and development. The initiative will operate on a ‘scientist in the loop’ model, where advanced AI supports and enhances the work of human researchers, marking a significant milestone for AI’s role in medicine. ...